We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




New Detection Method Spares Unnecessary Prostate Cancer Treatments

By MedImaging International staff writers
Posted on 18 Apr 2016
Scanning for prostate cancer for 3D modeling (Photo courtesy of St. George\'s University of London).
Scanning for prostate cancer for 3D modeling (Photo courtesy of St. George\'s University of London).
A novel three-dimensional (3D) cell model that mimics the morphogenesis of acini, the glandular units that constitute the prostate, could help study how prostate cancer (PC) progresses.

Developed by researchers at St. George's University of London, the 3D cellular model monitors the morphogenesis of the glandular structures using microscopy and imaging techniques, which can help identify the intraluminal hyperproliferation of the acini. By identifying the factors that alter the epithelial organization of acini that lead to the intraluminal proliferation, the researchers hope to develop a strategy that can help determine the causes of PC progression.

Using the 3D acini model, the researchers are developing methods that will provide objective measures for patient stratification and disease grading, which could thus complement current clinical classification of patients diagnosed with PC. By doing so, they hope to be able to consistently distinguish aggressive PC from indolent disease, a distinction currently difficult to identify, which often leads to inappropriate treatment and high morbidity and mortality.

“Based on these cell culture models, we believe a test could be developed to assess how invasive a prostate cell could become when taken from a patient,” said principal investigator Ferran Valderrama, PhD, of the SGUL PC cell biology laboratory. “We believe that this information would help to determine the appropriate treatment for the patient, reducing the burden derived from unnecessary over treatment, and overall having a positive outcome in patient survival.”

“The currently available prognostic tests for prostate cancer cannot conclusively tell us whether a tumor will rapidly progress and spread to other tissues, or instead will remain confined to the limits of the prostate,” added Dr. Ferran Valderrama. “Improving current procedures for predicting the outcome of a prostate that presents with ‘suspicious’ characteristics of prostate cancer are necessary. If we were able to determine that outcome in a consistent and conclusive manner, it would be easier to define the best approach for treatment for each individual case.”

Related Links:

St George's University of London
Computed Tomography System
Aquilion ONE / INSIGHT Edition
Half Apron
Demi
Pocket Fetal Doppler
CONTEC10C/CL
Radiation Safety Barrier
RayShield Intensi-Barrier

Channels

Nuclear Medicine

view channel
Image: CXCR4-targeted PET imaging reveals hidden inflammatory activity (Diekmann, J. et al., J Nucl Med (2025). DOI: 10.2967/jnumed.125.270807)

PET Imaging of Inflammation Predicts Recovery and Guides Therapy After Heart Attack

Acute myocardial infarction can trigger lasting heart damage, yet clinicians still lack reliable tools to identify which patients will regain function and which may develop heart failure.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.